Search

Genetic discovery using animal models: presbyacusis

By their very nature, late-onset hereditary disorders offer a large window of opportunity for therapeutic intervention. However, before we can begin to think about strategies we need knowledge of the genetics and pathology underlying the condition. In this article we...

Genomic testing for deafness and its implications

Gene therapies for hearing loss are rapidly advancing and will be transitioning to clinical practice. Here, the authors explain why clinicians involved in managing these disorders need to be aware of these advances. Genomic testing in England was significantly reconfigured...

IFOS 2026 bid cities

As Dubai prepares to host IFOS 2023, the next IFOS congress in 2026 is already being planned. The competition to host the meeting is certain to be fierce – we hear from the organisers around the world bidding to bring...

Jameel Muzaffar, Anne Schilder and James O’Hara

In a follow-up to the interview with Anne Schilder back in 2016*, Jameel Muzaffar speaks to Anne and to James O’Hara about the current research landscape in ENT in the UK. *Banerjee A. In conversation with Professor Anne Schilder. ENT...

Screening: evaluating the outcomes of early intervention

Newborn hearing screening is now the accepted standard of care in several countries, and is becoming increasingly more established worldwide. White [1] reported eight countries screening over 90% of newborns, ten screening between 25-89% of births and a further 54...

Audiovestibular findings in children with enlarged vestibular aqueduct

Enlarged vestibular aqueduct is reported to affect up to 15% of the paediatric population with sensorineural hearing loss. Devin McCaslin and Bridget Smith provide an up-to-date overview of the mechanisms and clinical symptoms underlying the condition and share some of...

OBITUARY: Professor David M Baguley (1961-2022)

Leader, teacher, mentor, scientist, clinician, patient advocate and man of faith: we will not see his like again. The sudden and tragic death of David (Dave) Baguley has left a gap within the national and international audiology and hearing science...

Implicit bias in audiology and wider healthcare

What is implicit bias and how might it affect patient outcomes in hearing healthcare? Yovina Khiroya provides insight into the terminology and the effect on people and service delivery. As much as possible within healthcare, we try to reduce implicit...

Current management of unilateral sporadic vestibular schwannoma

Vestibular schwannoma is the commonest tumour of the cerebellopontine angle (80%) and accounts for around 8% of all intracranial tumours. The commonest primary presenting symptoms are audio vestibular. Hearing health professionals are often the first contact for patients with potential symptoms of vestibular schwannoma, with the majority then being seen and diagnosed by otorhinolaryngologists.